Trade agreement doesn’t age well in a post-pandemic reality, with little mention of worker protections, environmental policy, or critical infrastructure.

Corporate lobbying and WTO pressure-cooker tactics killed the TRIPS waiver. Countries must find the courage to take on Big Pharma at home.

Where the U.S. has signalled worker-centred partnerships in Asia, Canada is pursuing more corporate trade deals.

The CUSMA automotive rules-of-origin dispute in perspective

A Canadian company’s successful challenge to a precautionary mining ban in Colombia shows how little investor–state dispute panels care about the right to regulate.